Research Summary
In-silico drug discovery, also known as computer-aided drug design, is a computational approach used to identify and optimize potential drug candidates before they are synthesized and tested in the laboratory. This methodology involves the use of computer algorithms, molecular modeling techniques, and bioinformatics tools to simulate and analyze the interactions between drug molecules and biological targets such as proteins, enzymes, or receptors. By leveraging large databases of chemical compounds, protein structures, and biological data, in-silico drug discovery enables researchers to predict the binding affinity, pharmacokinetic properties, and potential efficacy of candidate compounds in silico, thereby accelerating the drug discovery process and reducing the time and cost associated with traditional experimental approaches. In-silico methods play a crucial role in prioritizing promising drug candidates, optimizing lead compounds, and rationalizing drug design decisions, ultimately leading to the development of safer, more effective, and targeted therapeutics for various diseases.
According to DIResearch's in-depth investigation and research, the global In-Silico Drug Discovery market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of In-Silico Drug Discovery include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schr??dinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG) etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of In-Silico Drug Discovery. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global In-Silico Drug Discovery market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the In-Silico Drug Discovery market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Silico Drug Discovery industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of In-Silico Drug Discovery Include:
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schr??dinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
In-Silico Drug Discovery Product Segment Include:
Software as a Service
Consultancy as a Service
In-Silico Drug Discovery Product Application Include:
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global In-Silico Drug Discovery Industry PESTEL Analysis
Chapter 3: Global In-Silico Drug Discovery Industry Porter's Five Forces Analysis
Chapter 4: Global In-Silico Drug Discovery Major Regional Market Size and Forecast Analysis
Chapter 5: Global In-Silico Drug Discovery Market Size and Forecast by Type and Application Analysis
Chapter 6: North America In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa In-Silico Drug Discovery Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global In-Silico Drug Discovery Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 In-Silico Drug Discovery Market Overview 1.1 Product Definition and Statistical Scope 1.2 In-Silico Drug Discovery Product by Type 1.2.1 Global In-Silico Drug Discovery Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Software as a Service 1.2.3 Consultancy as a Service 1.3 In-Silico Drug Discovery Product by Application 1.3.1 Global In-Silico Drug Discovery Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Contract Research Organization 1.3.3 Pharmaceutical Industry 1.3.4 Academic and Research Institutes 1.3.5 Others 1.4 Global In-Silico Drug Discovery Market Revenue Analysis (2019-2030) 1.5 In-Silico Drug Discovery Market Development Status and Trends 1.5.1 In-Silico Drug Discovery Industry Development Status Analysis 1.5.2 In-Silico Drug Discovery Industry Development Trends Analysis 2 In-Silico Drug Discovery Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 In-Silico Drug Discovery Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global In-Silico Drug Discovery Market Analysis by Regions 4.1 In-Silico Drug Discovery Overall Market: 2023 VS 2024 VS 2030 4.2 Global In-Silico Drug Discovery Revenue and Forecast Analysis (2019-2030) 4.2.1 Global In-Silico Drug Discovery Revenue and Market Share by Region (2019-2024) 4.2.2 Global In-Silico Drug Discovery Revenue Forecast by Region (2025-2030) 5 Global In-Silico Drug Discovery Market Size by Type and Application 5.1 Global In-Silico Drug Discovery Market Size by Type 5.2 Global In-Silico Drug Discovery Market Size by Application 6 North America 6.1 North America In-Silico Drug Discovery Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America In-Silico Drug Discovery Market Size by Type 6.4 North America In-Silico Drug Discovery Market Size by Application 6.5 North America In-Silico Drug Discovery Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe In-Silico Drug Discovery Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe In-Silico Drug Discovery Market Size by Type 7.4 Europe In-Silico Drug Discovery Market Size by Application 7.5 Europe In-Silico Drug Discovery Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China In-Silico Drug Discovery Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China In-Silico Drug Discovery Market Size by Type 8.4 China In-Silico Drug Discovery Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) In-Silico Drug Discovery Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) In-Silico Drug Discovery Market Size by Type 9.4 APAC (excl. China) In-Silico Drug Discovery Market Size by Application 9.5 APAC (excl. China) In-Silico Drug Discovery Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America In-Silico Drug Discovery Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America In-Silico Drug Discovery Market Size by Type 10.4 Latin America In-Silico Drug Discovery Market Size by Application 10.5 Latin America In-Silico Drug Discovery Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa In-Silico Drug Discovery Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa In-Silico Drug Discovery Market Size by Type 11.4 Middle East & Africa In-Silico Drug Discovery Market Size by Application 11.5 Middle East & Africa In-Silico Drug Discovery Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global In-Silico Drug Discovery Market Revenue by Key Manufacturers (2020-2024) 12.2 In-Silico Drug Discovery Competitive Landscape Analysis and Market Dynamic 12.2.1 In-Silico Drug Discovery Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Charles River 13.1.1 Charles River Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Charles River In-Silico Drug Discovery Product Portfolio 13.1.3 Charles River In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Certara USA, Inc. 13.2.1 Certara USA, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Certara USA, Inc. In-Silico Drug Discovery Product Portfolio 13.2.3 Certara USA, Inc. In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Evotec 13.3.1 Evotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Evotec In-Silico Drug Discovery Product Portfolio 13.3.3 Evotec In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Dassault System (Biovia) 13.4.1 Dassault System (Biovia) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Dassault System (Biovia) In-Silico Drug Discovery Product Portfolio 13.4.3 Dassault System (Biovia) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Albany Molecular Research Inc. (AMRI) 13.5.1 Albany Molecular Research Inc. (AMRI) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product Portfolio 13.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Selvita 13.6.1 Selvita Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Selvita In-Silico Drug Discovery Product Portfolio 13.6.3 Selvita In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Schr??dinger, Inc. 13.7.1 Schr??dinger, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Schr??dinger, Inc. In-Silico Drug Discovery Product Portfolio 13.7.3 Schr??dinger, Inc. In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 GVK BIO 13.8.1 GVK BIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 GVK BIO In-Silico Drug Discovery Product Portfolio 13.8.3 GVK BIO In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 OpenEye Scientific Software 13.9.1 OpenEye Scientific Software Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 OpenEye Scientific Software In-Silico Drug Discovery Product Portfolio 13.9.3 OpenEye Scientific Software In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Chemical Computing Group (CCG) 13.10.1 Chemical Computing Group (CCG) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Chemical Computing Group (CCG) In-Silico Drug Discovery Product Portfolio 13.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 In-Silico Drug Discovery Industry Chain Analysis 14.2 In-Silico Drug Discovery Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 In-Silico Drug Discovery Typical Downstream Customers 14.4 In-Silico Drug Discovery Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Blockchain in Healthcare Market By Blockchain (Public Blockchain, Private Blockchain, Hybrid Blockchain, Others), By Application (Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing, Others), By End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Vector Graphics Software Competitive Landscape Professional Research Report 2024
- Global Veterinary Clinics Services Competitive Landscape Professional Research Report 2024
- Global Second-hand Commodity Trading Platform Competitive Landscape Professional Research Report 2024
- Global UV Disinfection Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support